Similar articles

• Embryopathy in infant conceived one year after termination of maternal etretinate.

  Lammer EJ. Lammer EJ. Lancet. 1988 Nov 5;2(8619):1080-1. doi: 10.1016/s0140-6736(88)90101-8. Lancet. 1988. PMID: 2903308 No abstract available.
• Malformation of fetus conceived 4 months after termination of maternal etretinate treatment.

  Grote W, Harms D, Jänig U, Kietzmann H, Ravens U, Schwarze I. Grote W, et al. Lancet. 1985 Jun 1;1(8440):1276. doi: 10.1016/s0140-6736(85)92344-x. Lancet. 1985. PMID: 2860474 No abstract available.
• [Embryonal malformation following etretinate therapy of Darier's disease in the mother].

  Kietzmann H, Schwarze I, Grote W, Ravens U, Jänig U, Harms D. Kietzmann H, et al. Dtsch Med Wochenschr. 1986 Jan 10;111(2):60-2. doi: 10.1055/s-2008-1068402. Dtsch Med Wochenschr. 1986. PMID: 3940838 German.
• Teratogenic risk with etretinate and acitretin treatment.

  Geiger JM, Baudin M, Saurat JH. Geiger JM, et al. Dermatology. 1994;189(2):109-16. doi: 10.1159/000246811. Dermatology. 1994. PMID: 8075435 Review.
• [Alcoholic embryopathy].

  Holtorff J, Hinkel GK. Holtorff J, et al. Z Gesamte Inn Med. 1981 Aug 15;36(16):587-93. Z Gesamte Inn Med. 1981. PMID: 7027654 Review. German.